To ask the Secretary of State for Health and Social Care, to make an assessment of the capacity to deliver Early Access Programmes for people with motor neurone disease.
Companies may put in place Early Access Programmes (EAPs) to allow early access to new medicines that do not yet have a marketing authorisation. Participation in EAPs is decided at an individual National Health Service trust level and under these programm...
Motor Neurone Disease: Health Services